COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
04/06/2026
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources GAITHERSBURG, Md., June 04, 2026 (GLOBE NEWSWIRE) -- In [...]
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
04/06/2026
FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular [...]
Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer
04/06/2026
WASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- The Melanoma Research Alliance (MRA), the world's leading nonprofit funder of melanoma research, today announced the appointment of Stephanie Kauffman as Chief Executive [...]
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
04/06/2026
First-in-human Phase I study met its primary endpoint, demonstrating favourable safety and tolerability in healthy volunteers in the single ascending dose part of the study Phase I data demonstrate statistically [...]
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
04/06/2026
MELBOURNE, Australia, June 04, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the establishment of a new Gelteq Center of Excellence in Guangdong Province, China. The Gelteq Center of Excellence will [...]
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
04/06/2026
BELTSVILLE, Md., June 04, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel therapies to treat cancer, today announced the [...]
IMUNON Announces Up to $10 Million Cash Financing
04/06/2026
Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.72 million Uniquely structured, flexible financing supports IMUNON’s Highly Anticipated Phase 3 OVATION 3 Study of IMNN- [...]
SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery
04/06/2026
Cardiac telesurgery performed by Dr. Sudhir Srivastava utilizing the SSi Mantra surgical robotic system from Guyana, at a line distance of approximately 12,500 miles (20,000 kilometers) to the patient in India FORT [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
04/06/2026
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- -Follows Orphan Drug Designation, Pediatric Rare Disease Designation, and Fast Track [...]
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
04/06/2026
Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and Ampligen’s previously published antiviral research Discussion highlights Ampligen’s immune-modulating mechanism, [...]
America's Caregiving Dilemma: 90% Burnout, a Gen Z Reckoning, and the AI Lifeline Families Need
04/06/2026
LogicMark Survey Reveals Americans Avoiding Conversation Around Caregiving; Crisis Is Generational, Financial, and Hidden in Plain Sight LOUISVILLE, Ky., June 04, 2026 (GLOBE NEWSWIRE) -- A comprehensive new national [...]
Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
04/06/2026
LillyDirect customers can now connect to Weight Watchers Med+ program, an integrated GLP-1 access and care model, driving greater weight loss results than medication alone NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WW [...]
Better Blend Brings a New Kind of Fast Casual to Tampa Bay
04/06/2026
The growing smoothie and bowl concept combines speed and better-for-you options as it enters the region TAMPA, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- What consumers expect from fast casual is changing. While speed and [...]
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026
04/06/2026
Discussion highlights growing importance on novel ADC payloads, and Akari’s ASCO data in KRAS-driven cancers and future potential Access the Akari CEO Corner here TAMPA, Fla. and LONDON, June 04, 2026 (GLOBE NEWSWIRE [...]
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
04/06/2026
LANGHORNE, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Free Brain Health Assessments Available During June
04/06/2026
Free Memory Screenings Offered Across the Country during Alzheimer’s and Brain Awareness Month WASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- Alzheimer’s research sites across the country are recognizing Alzheimer’s and [...]
Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies
04/06/2026
– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies tumor-specific cell surface [...]
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04/06/2026
FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued demonstration of [...]

Pages